Vaccines and Antiviral Agents | Spotlight

GSK3732394: a Multi-specific Inhibitor of HIV Entry

David Wensel, Yongnian Sun, Jonathan Davis, Zhufang Li, Sharon Zhang, Thomas McDonagh, David Langley, Tracy Mitchell, Sebastien Tabruyn, Patrick Nef, Mark Cockett, Mark Krystal
Viviana Simon, Editor
DOI: 10.1128/JVI.00907-19

Article Information

DOI 
https://doi.org/10.1128/JVI.00907-19
PubMed 
31375580
Published By 
American Society for Microbiology Journals
History 
  • Received May 29, 2019
  • Accepted July 19, 2019
  • Published online September 30, 2019.
Copyright & Usage 
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers 
  • Viviana Simon, Editor, Icahn School of Medicine at Mount Sinai

Article Versions

Author Information

  1. David Wensela,
  2. Yongnian Sunb,
  3. Jonathan Davisc,
  4. Zhufang Lia,
  5. Sharon Zhanga,
  6. Thomas McDonaghc,
  7. David Langleyb,
  8. Tracy Mitchellc,
  9. Sebastien Tabruynd,
  10. Patrick Nefd,
  11. Mark Cocketta and
  12. Mark Krystala
  1. aViiV Healthcare, Branford, Connecticut, USA
  2. bBristol-Myers Squibb, Wallingford, Connecticut, USA
  3. cBristol-Myers Squibb, Waltham, Massachusetts, USA
  4. dTransCure bioServices, Archamps, France
  • Address correspondence to Mark Krystal, Mark.R.Krystal{at}viivhealthcare.com.

  • Citation Wensel D, Sun Y, Davis J, Li Z, Zhang S, McDonagh T, Langley D, Mitchell T, Tabruyn S, Nef P, Cockett M, Krystal M. 2019. GSK3732394: a multi-specific inhibitor of HIV entry. J Virol 93:e00907-19. https://doi.org/10.1128/JVI.00907-19.

View Full Text

Article usage

Article usage: July 2019 to February 2020

Rendering graph...
AbstractFullPdf
Jul 2019101
Aug 2019460069
Sep 20193892243
Oct 2019431131107
Nov 2019922323
Dec 2019821324
Jan 2020842239
Feb 2020471132
Back to top
Download PDF
Citation Tools
Print

Alerts
Email

KEYWORDS

CD4
HIV entry
adnectins
gp41
inhibitor
synergy

Related Articles

Cited By...